Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Glioblastoma × Valacyclovir × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Infectious Mononucleosis 1 Glioblastoma 1 Epstein-Barr Virus Infections 1

Interventions

Temozolomide 60 Radiotherapy 25 Bevacizumab 22 Carboplatin 12 Radiation 11 pembrolizumab 10 Irinotecan 7 Surgical Procedures, Operative 6 Carmustine 6 Radiosurgery 5 Nivolumab 5 Everolimus 5 Erlotinib Hydrochloride 5 temsirolimus 4 atezolizumab 4 Vorinostat 4 Lomustine 4 Aminolevulinic Acid 4 tipifarnib 3 Sirolimus 3 Radiotherapy, Intensity-Modulated 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 IL13-PE38 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 Drug Therapy 3 Cetuximab 3 selinexor 2 poly ICLC 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346144 2026-03-04

ADePT

Trogenix ltd

Phase 1/2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡